|
Title: |
|
Authors:
|
|
Abstract: Background-Aims: To
elucidate the importance of Wnt signaling pathway and its connection with
E-cadherin and β-catenin in esophageal
adenocarcinoma as well as the expression levels of β-catenin and E-cadherin as potential biomarkers.
Methodology: The study was
retrospectively collected by the archives of the First Laboratory of
Pathology of the Medical School of the National and Kapodistrian University in
Athens, Greece. Seventy-one (n=71) patients with Esophageal Adenocarcinoma (EA)
were included in this two years study (2023-2025) to examine the association
between β-catenin and esophageal adenocarcinoma.
Results: A total of 71
histopathologically confirmed cases of esophageal adenocarcinoma were analyzed.
Immunohistochemical assessment of E-cadherin and β-catenin expression revealed a moderate positive correlation between
cytoplasmic β-catenin levels and Tumor Regression Grade (TRG). Furthermore, a strong
positive correlation was observed between cytoplasmic and nuclear expression of
b-catenin, suggesting that increased cytoplasmic accumulation is associated
with enhanced nuclear localization, indicative of Wnt pathway activation.
Additionally, a positive correlation was identified between E-cadherin
expression and TRG, whereby higher levels of E-cadherin expression were
associated with improved therapeutic response.
Conclusions: Simultaneous targeting of β-catenin and E-cadherin may present a therapeutic strategy in esophageal adenocarcinoma and holds promise for their utilization as prognostic biomarkers. DOI: http://dx.doi.org/10.51505/ijmshr.2025.9507 |
|
PDF Download |